| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 10, 2018
DUBLIN - April 10, 2018 - Medtronic plc (NYSE: MDT) announced today the CE (Conformité Européenne) Mark and European launch of the Visualase(TM) MRI-Guided Laser Ablation System. The Visualase...
-
Mar 10, 2018Presented at ACC.18, Five-Year Follow-up from the CoreValve Extreme Risk and NOTION Studies Show Sustained Valve Function and Durability Over Time
DUBLIN and ORLANDO - March 10, 2018 - Medtronic plc (NYSE: MDT) today unveiled outcomes from the CoreValve U.S. Pivotal Extreme Risk Study and the real-world NOTION trial (Nordic Aortic Valve...
-
Feb 26, 2018FDA Approved, Resolute Onyx 2.0 mm DES Technology Tackles Clinical Challenge of Treating Coronary Artery Disease in Previously Untreatable Patients
DUBLIN - February 26, 2018 - Designed specifically for small vessels, Medtronic plc (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Resolute...
-
Feb 21, 2018New Infusion Set Offers Simpler, Faster, and More Convenient1 Insulin Pump Experience
DUBLIN - February 21, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, today introduced the MiniMed(TM) Mio(TM) Advance infusion set. The MiniMed...
-
Feb 20, 2018Revenue of $7.4 Billion Increased 1% as Reported; 7% at Comparable, Constant Currency
DUBLIN - February 20, 2108 - Medtronic plc (NYSE: MDT) today announced financial results for its third quarter of fiscal year 2018, which ended January 26, 2018. The company reported third quarter...
-
Jan 30, 2018Data Presented at LINC 2018 Highlight IN.PACT Admiral as Safe and Effective Treatment Option in PAD
DUBLIN and LEIPZIG - January 30, 2018 - Medtronic plc (NYSE: MDT) today added to its robust body of clinical evidence supporting the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) with new...
-
Jan 26, 2018Study to Enroll Subjects at up to 35 Sites Across the U.S. and Europe
DUBLIN - January 26, 2018 - Medtronic plc (NYSE: MDT) today announced the initiation of its investigational device exemption (IDE) study for the Abre(TM) venous self-expanding stent system. The...
-
Jan 24, 2018Clinical Study to Investigate the Performance of the ChEVAR Technique in AAA Patients with Short Aortic Necks
DUBLIN - January 24, 2018 - Medtronic plc (NYSE: MDT) today announced the launch of the ENCHANT (ENdurant CHEVAR New Indication Trial) study. The post-market, non-interventional, multi-center,...
-
Nov 27, 2017Medtronic Care Management Services Delivers on Its Commitment to Serve Veteran Patients with Expanded Suite of Telehealth Solutions
DUBLIN - November 27, 2017 - Medtronic plc (NYSE:MDT) today announced its Medtronic Care Management Services (MCMS) business commenced launch of new telehealth solutions in support of its national...
-
Nov 21, 2017Revenue of $7.1 Billion; GAAP Diluted EPS of $1.48; Non-GAAP Diluted EPS of $1.07
DUBLIN - November 21, 2017 - Medtronic plc (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2018, which ended October 27, 2017. The company reported second...